-+ 0.00%
-+ 0.00%
-+ 0.00%

GT BIOPHARMA - PHASE 1 TRIAL WITH GTB-5550 IN SOLID TUMORS ACTIVELY ENROLLING, UPDATE EXPECTED Q4 2026

Reuters·09/15/2026 13:15:00

Please log in to view news